Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805659 · ClinicalTrials.gov registry record · NA
HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03805659: Completed NA study, sponsored by Medical College of Wisconsin.
NCT03805659 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03805659, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study aims to evaluate the effectiveness of a therapy called High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for the treatment of the language deficits experienced by people with a type of Primary Progressive Aphasia. This study uses a combination of brain imaging, language assessment, language training sessions, and HD-tDCS therapy as well as placebo therapy sessions.
Primary Outcome
Language performance as assessed at baseline and post-stimulation procedure
Interventions
- DEVICE Sham
- DEVICE HD-tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-05-18 |
| Phase | NA |
What the finished NCT03805659 record still lists
NCT03805659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT03805659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03805659 about?
NCT03805659 is a clinical study titled "HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms". This study aims to evaluate the effectiveness of a therapy called High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for the treatment of the language deficits experienced by people with a type of Primary Progressive Aphasia. This study uses a combination of brain imaging, language as...
What is the current status of trial NCT03805659?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-02-24. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT03805659?
The interventions under investigation include: Sham (DEVICE), HD-tDCS (DEVICE).
Who is sponsoring clinical trial NCT03805659?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03805659's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI